Form CORRESP - Correspondence:
SEC Accession No. 0001193125-24-022834
Filing Date
2024-02-02
Accepted
2024-02-02 16:01:55
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 4192
  Complete submission text file 0001193125-24-022834.txt   5293
Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)